John Wall injury: Wizards guard to have knee re-examined Friday

Kevin C. Cox

The same doctor who diagnosed the injury will re-evaluate John Wall.

The Washington Wizards will be hoping for good news on Friday. That's when John Wall will have his knee re-examined by the same doctor that originally diagnosed him, as reported by Chris Broussard of ESPN.com.

Wall will be in New York on Friday to visit Dr. David Altchek. The hope is that the doctor will be able to give Washington a more specific timetable as to when the team's point guard will return.

After seeing Altchek the first time, the Wizards announced that Wall would be out for about eight weeks. It is now approaching the 12-week mark.

Without Wall, the Wizards have started the season with a 3-16 record. It has been a revolving door at point guard, as A.J. Price is also injured for Washington.

A return by Wall would be a big boost for the Wizards. A season ago, he averaged 16.3 points and eight assists per game.

X
Log In Sign Up

forgot?
Log In Sign Up

Forgot password?

We'll email you a reset link.

If you signed up using a 3rd party account like Facebook or Twitter, please login with it instead.

Forgot password?

Try another email?

Almost done,

By becoming a registered user, you are also agreeing to our Terms and confirming that you have read our Privacy Policy.

Join SBNation.com

You must be a member of SBNation.com to participate.

We have our own Community Guidelines at SBNation.com. You should read them.

Join SBNation.com

You must be a member of SBNation.com to participate.

We have our own Community Guidelines at SBNation.com. You should read them.

Spinner.vc97ec6e

Authenticating

Great!

Choose an available username to complete sign up.

In order to provide our users with a better overall experience, we ask for more information from Facebook when using it to login so that we can learn more about our audience and provide you with the best possible experience. We do not store specific user data and the sharing of it is not required to login with Facebook.